Karuna Therapeutics, Inc.: cashflow_investing

Value{"amount": -252761000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2023-01-01 – 2023-09-30
Statuscurrent
EntityKaruna Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-23-057731 · Open the official SEC filing →
Retrieved: 2026-08-19T17:58:31.608088+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001771917/cashflow-investing/2023-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/f8d7afec-3afe-4858-95cf-37c94c26e372

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies